{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:21:53Z","timestamp":1772119313590,"version":"3.50.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T00:00:00Z","timestamp":1758067200000},"content-version":"vor","delay-in-days":16,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Programa Nacional de Apoio \u00e0 Aten\u00e7\u00e3o Oncol\u00f3gica = National Support Program for Oncological Care"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1007\/s00277-025-06437-4","type":"journal-article","created":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T02:25:06Z","timestamp":1758075906000},"page":"4495-4503","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Challenges in accuracy in molecular genetic diagnosis of childhood AML: case series"],"prefix":"10.1007","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1356-2497","authenticated-orcid":false,"given":"Fernanda","family":"de Oliveira Mota","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silva Regina Caminada","family":"de Toledo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francine","family":"Tesser-Gamba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele Gaboardi de Carvalho","family":"Pires","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juliana Thomazini","family":"Gouveia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Indhira Dias","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nancy","family":"da Silva Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabete","family":"Delbuono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno Nicolaz","family":"Rhein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renata Fittipaldi da Costa","family":"Guimar\u00e3es","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victor Gottardello","family":"Zecchin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Lucia","family":"de Martino Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8479-6322","authenticated-orcid":false,"given":"Ana Virginia Lopes","family":"de Sousa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,9,17]]},"reference":[{"issue":"4","key":"6437_CR1","doi-asserted-by":"publisher","first-page":"1968","DOI":"10.3390\/ijms23041968","volume":"23","author":"M Lejman","year":"2022","unstructured":"Lejman M, Dziatkiewicz I, Jurek M (2022) Straight to the Point\u2014The novel strategies to cure pediatric AML. Int J Mol Sci 23(4):1968. https:\/\/doi.org\/10.3390\/ijms23041968","journal-title":"Int J Mol Sci"},{"issue":"27","key":"6437_CR2","doi-asserted-by":"publisher","first-page":"2949","DOI":"10.1200\/jco.2015.62.8289","volume":"33","author":"CM Zwaan","year":"2015","unstructured":"Zwaan CM, Kolb EA, Reinhardt D et al (2015) Collaborative efforts driving progress in pediatric acute myeloid leukemia. J Clin Oncol 33(27):2949\u20132962. https:\/\/doi.org\/10.1200\/jco.2015.62.8289","journal-title":"J Clin Oncol"},{"issue":"10","key":"6437_CR3","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.1038\/s41375-018-0071-7","volume":"32","author":"M Rasche","year":"2018","unstructured":"Rasche M, Zimmermann M, Borschel L et al (2018) Successes and challenges in the treatment of pediatric acute myeloid leukemia: a retrospective analysis of the AML-BFM trials from 1987 to 2012. Leukemia 32(10):2167\u20132177. https:\/\/doi.org\/10.1038\/s41375-018-0071-7","journal-title":"Leukemia"},{"key":"6437_CR4","doi-asserted-by":"publisher","unstructured":"Conneely SE, Stevens AM (2021) Acute myeloid leukemia in children: emerging paradigms in genetics and new approaches to therapy. Curr Oncol Rep 23(2). https:\/\/doi.org\/10.1007\/s11912-020-01009-3","DOI":"10.1007\/s11912-020-01009-3"},{"issue":"9","key":"6437_CR5","doi-asserted-by":"publisher","first-page":"2058","DOI":"10.3390\/cancers14092058","volume":"14","author":"J Suttorp","year":"2022","unstructured":"Suttorp J, L\u00fchmann JL, Behrens YL et al (2022) Optical genome mapping as a diagnostic tool in pediatric acute myeloid leukemia. Cancers 14(9):2058. https:\/\/doi.org\/10.3390\/cancers14092058","journal-title":"Cancers"},{"issue":"1","key":"6437_CR6","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s10555-020-09846-1","volume":"39","author":"SE Conneely","year":"2020","unstructured":"Conneely SE, Rau RE (2020) The genomics of acute myeloid leukemia in children. Cancer Metastasis Rev 39(1):189\u2013209. https:\/\/doi.org\/10.1007\/s10555-020-09846-1","journal-title":"Cancer Metastasis Rev"},{"issue":"1","key":"6437_CR7","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1002\/hon.2709","volume":"38","author":"B Kim","year":"2020","unstructured":"Kim B, Kim E, Lee S et al (2020) Detection of recurrent, rare, and novel gene fusions in patients with acute leukemia using next-generation sequencing approaches. Hematol Oncol 38(1):82\u201388. https:\/\/doi.org\/10.1002\/hon.2709","journal-title":"Hematol Oncol"},{"issue":"20","key":"6437_CR8","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","volume":"127","author":"DA Arber","year":"2016","unstructured":"Arber DA, Orazi A, Hasserjian R et al (2016) The 2016 revision to the world health organization classification of myeloid neoplasms and acute leukemia. Blood 127(20):2391\u20132405. https:\/\/doi.org\/10.1182\/blood-2016-03-643544","journal-title":"Blood"},{"issue":"6","key":"6437_CR9","doi-asserted-by":"publisher","first-page":"924","DOI":"10.3390\/genes12060924","volume":"12","author":"J Quessada","year":"2021","unstructured":"Quessada J, Cuccuini W, Saultier P, Loosveld M, Harrison CJ, Lafage-Pochitaloff M (2021) Cytogenetics of pediatric acute myeloid leukemia: a review of the current knowledge. Genes 12(6):924. https:\/\/doi.org\/10.3390\/genes12060924","journal-title":"Genes"},{"key":"6437_CR10","doi-asserted-by":"publisher","unstructured":"Egan G, Chopra Y, Mourad S, Chiang K, Hitzler J (2021) Treatment of acute myeloid leukemia in children: a practical perspective. Pediatr Blood Amp Cancer 68(7). https:\/\/doi.org\/10.1002\/pbc.28979","DOI":"10.1002\/pbc.28979"},{"issue":"1","key":"6437_CR11","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1097\/MOP.0000000000000855","volume":"32","author":"CW Elgarten","year":"2020","unstructured":"Elgarten CW, Aplenc R (2020) Pediatric acute myeloid leukemia: updates on biology, risk stratification, and therapy. Curr Opin Pediatr 32(1):57\u201366. https:\/\/doi.org\/10.1097\/MOP.0000000000000855","journal-title":"Curr Opin Pediatr"},{"issue":"2","key":"6437_CR12","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.canlet.2012.11.025","volume":"340","author":"J Xuan","year":"2013","unstructured":"Xuan J, Yu Y, Qing T, Guo L, Shi L (2013) Next-generation sequencing in the clinic: promises and challenges. Cancer Lett 340(2):284\u2013295. https:\/\/doi.org\/10.1016\/j.canlet.2012.11.025","journal-title":"Cancer Lett"},{"key":"6437_CR13","doi-asserted-by":"publisher","unstructured":"Bansal D, Davidson A, Supriyadi E, Njuguna F, Ribeiro RC, Kaspers GJL (2019) SIOP PODC adapted risk stratification and treatment guidelines: recommendations for acute myeloid leukemia in resource-limited settings [published online ahead of print, 2019 Nov 27]. Pediatr Blood Cancer e28087. https:\/\/doi.org\/10.1002\/pbc.28087","DOI":"10.1002\/pbc.28087"},{"issue":"8","key":"6437_CR14","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/j.arcmed.2016.11.015","volume":"47","author":"FG Andrade","year":"2016","unstructured":"Andrade FG, Noronha EP, Brisson GD et al (2016) Molecular characterization of pediatric acute myeloid leukemia: results of a multicentric study in Brazil. Arch Med Res 47(8):656\u2013667. https:\/\/doi.org\/10.1016\/j.arcmed.2016.11.015","journal-title":"Arch Med Res"},{"key":"6437_CR15","doi-asserted-by":"publisher","unstructured":"Lins MM, Mello MJG, Ribeiro RC, De Camargo B F\u00e1tima Pessoa Milit\u00e3o, de Albuquerque M, Thuler LCS (2019) Survival and risk factors for mortality in pediatric patients with acute myeloid leukemia in a single reference center in low-middle-income country. Ann Hematol.;98(6):1403\u20131411. https:\/\/doi.org\/10.1007\/s00277-019-03661-7","DOI":"10.1007\/s00277-019-03661-7"},{"issue":"1","key":"6437_CR16","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3343\/alm.2021.41.1.25","volume":"41","author":"Y Zhong","year":"2021","unstructured":"Zhong Y, Xu F, Wu J, Schubert J, Li MM (2021) Application of next generation sequencing in laboratory medicine. Ann Lab Med 41(1):25\u201343. https:\/\/doi.org\/10.3343\/alm.2021.41.1.25","journal-title":"Ann Lab Med"},{"key":"6437_CR17","doi-asserted-by":"publisher","first-page":"215","DOI":"10.3389\/fgene.2015.00215","volume":"6","author":"T Shen","year":"2015","unstructured":"Shen T, Pajaro-Van de Stadt SH, Yeat NC, Lin JC (2015) Clinical applications of next generation sequencing in cancer: from panels, to exomes, to genomes. Front Genet 6:215 Published 2015 Jun 17. https:\/\/doi.org\/10.3389\/fgene.2015.00215","journal-title":"Front Genet"},{"key":"6437_CR18","doi-asserted-by":"publisher","first-page":"263","DOI":"10.3389\/fped.2017.00263","volume":"5","author":"E Lalonde","year":"2017","unstructured":"Lalonde E, Wertheim G, Li MM (2017) Clinical impact of genomic information in pediatric leukemia. Front Pediatr 5:263 Published 2017 Dec 14. https:\/\/doi.org\/10.3389\/fped.2017.00263","journal-title":"Front Pediatr"},{"issue":"5","key":"6437_CR19","doi-asserted-by":"publisher","first-page":"46","DOI":"10.3892\/br.2020.1353","volume":"13","author":"H Ishida","year":"2020","unstructured":"Ishida H, Iguchi A, Aoe M et al (2020) Panel-based next-generation sequencing facilitates the characterization of childhood acute myeloid leukemia in clinical settings. Biomed Rep 13(5):46. https:\/\/doi.org\/10.3892\/br.2020.1353","journal-title":"Biomed Rep"},{"key":"6437_CR20","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.cancergen.2021.01.007","volume":"254\u2013255","author":"MC Hiemenz","year":"2021","unstructured":"Hiemenz MC, Oberley MJ, Doan A et al (2021) A multimodal genomics approach to diagnostic evaluation of pediatric hematologic malignancies. Cancer Genet 254\u2013255:25\u201333. https:\/\/doi.org\/10.1016\/j.cancergen.2021.01.007","journal-title":"Cancer Genet"},{"issue":"16","key":"6437_CR21","doi-asserted-by":"publisher","first-page":"3187","DOI":"10.1182\/blood-2012-03-362608","volume":"120","author":"U Creutzig","year":"2012","unstructured":"Creutzig U, van den Heuvel-Eibrink MM, Gibson B et al (2012) Diagnosis and management of acute myeloid leukemia in children and adolescents: recommendations from an international expert panel. Blood 120(16):3187\u20133205. https:\/\/doi.org\/10.1182\/blood-2012-03-362608","journal-title":"Blood"},{"issue":"3","key":"6437_CR22","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1200\/JCO.1991.9.3.416","volume":"9","author":"VM Santana","year":"1991","unstructured":"Santana VM, Mirro J Jr, Harwood FC et al (1991) A phase I clinical trial of 2-chlorodeoxyadenosine in pediatric patients with acute leukemia. J Clin Oncol 9(3):416\u2013422. https:\/\/doi.org\/10.1200\/JCO.1991.9.3.416","journal-title":"J Clin Oncol"},{"issue":"10","key":"6437_CR23","doi-asserted-by":"publisher","first-page":"e29812","DOI":"10.1002\/pbc.29812","volume":"69","author":"ES Schafer","year":"2022","unstructured":"Schafer ES, Chao K, Stevens AM et al (2022) Real-world experience in treating pediatric relapsed\/refractory or therapy-related myeloid malignancies with decitabine, Vorinostat, and FLAG therapy based on a phase 1 study run by the TACL consortium. Pediatr Blood Cancer 69(10):e29812. https:\/\/doi.org\/10.1002\/pbc.29812","journal-title":"Pediatr Blood Cancer"},{"issue":"4","key":"6437_CR24","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1080\/10428194.2018.1508670","volume":"60","author":"J Westhus","year":"2018","unstructured":"Westhus J, Noppeney R, D\u00fchrsen U, Hanoun M (2018) FLAG salvage therapy combined with Idarubicin in relapsed\/refractory acute myeloid leukemia. Leuk Lymphoma 60(4):1014\u20131022. https:\/\/doi.org\/10.1080\/10428194.2018.1508670","journal-title":"Leuk Lymphoma"},{"key":"6437_CR25","unstructured":"Oncomine childhood research assay| thermo fisher scientific - DE Thermo Fisher Scientific - DE. Acedido em 30 de maio de 2023. https:\/\/www.thermofisher.com\/br\/en\/home\/clinical\/preclinical-companion-diagnostic-development\/oncomine-oncology\/oncomine-childhood-research-assay.html"},{"key":"6437_CR26","doi-asserted-by":"publisher","unstructured":"Mohanty S, Jyotsana N, Sharma A et al (2020) Targeted Inhibition of the NUP98-NSD1 Fusion Oncogene in Acute Myeloid Leukemia. Cancers (Basel) 12(10):2766. Published 2020 Sep 26. https:\/\/doi.org\/10.3390\/cancers12102766","DOI":"10.3390\/cancers12102766"},{"key":"6437_CR27","doi-asserted-by":"publisher","unstructured":"Niktoreh N, Walter C, Zimmermann M, Mutated et al (2019) WT1, FLT3-ITD, and NUP98-NSD1 Fusion in Various Combinations Define a Poor Prognostic Group in Pediatric Acute Myeloid Leukemia. J Oncol 2019:1609128. Published 2019 Jul 30. https:\/\/doi.org\/10.1155\/2019\/1609128","DOI":"10.1155\/2019\/1609128"},{"issue":"7","key":"6437_CR28","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1002\/gcc.22064","volume":"52","author":"N Shiba","year":"2013","unstructured":"Shiba N, Ichikawa H, Taki T et al (2013) NUP98-NSD1 gene fusion and its related gene expression signature are strongly associated with a poor prognosis in pediatric acute myeloid leukemia. Genes Chromosomes Cancer 52(7):683\u2013693. https:\/\/doi.org\/10.1002\/gcc.22064","journal-title":"Genes Chromosomes Cancer"},{"issue":"17","key":"6437_CR29","doi-asserted-by":"publisher","first-page":"3790","DOI":"10.3390\/jcm10173790","volume":"10","author":"M Algeri","year":"2021","unstructured":"Algeri M, Merli P, Locatelli F, Pagliara D (2021) The role of allogeneic hematopoietic stem cell transplantation in pediatric leukemia. J Clin Med 10(17):3790. https:\/\/doi.org\/10.3390\/jcm10173790. Published 2021 Aug 25","journal-title":"J Clin Med"},{"issue":"3","key":"6437_CR30","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/leu.2016.267","volume":"31","author":"S Struski","year":"2017","unstructured":"Struski S, Lagarde S, Bories P et al (2017) NUP98 is rearranged in 3.8% of pediatric AML forming a clinical and molecular homogenous group with a poor prognosis. Leukemia 31(3):565\u2013572. https:\/\/doi.org\/10.1038\/leu.2016.267","journal-title":"Leukemia"},{"issue":"13","key":"6437_CR31","doi-asserted-by":"publisher","first-page":"3645","DOI":"10.1182\/blood-2011-04-346643","volume":"118","author":"IH Hollink","year":"2011","unstructured":"Hollink IH, van den Heuvel-Eibrink MM, Arentsen-Peters ST et al (2011) NUP98\/NSD1 characterizes a novel poor prognostic group in acute myeloid leukemia with a distinct HOX gene expression pattern. Blood 118(13):3645\u20133656. https:\/\/doi.org\/10.1182\/blood-2011-04-346643","journal-title":"Blood"},{"issue":"Pt 4","key":"6437_CR32","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1107\/S2053230X15004793","volume":"71","author":"BH Ha","year":"2015","unstructured":"Ha BH, Simpson MA, Koleske AJ, Boggon TJ (2015) Structure of the ABL2\/ARG kinase in complex with dasatinib. Acta Crystallogr F Struct Biol Commun 71(Pt 4):443\u2013448. https:\/\/doi.org\/10.1107\/S2053230X15004793","journal-title":"Acta Crystallogr F Struct Biol Commun"},{"issue":"1","key":"6437_CR33","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1182\/bloodadvances.2019000709","volume":"4","author":"Y Ishikawa","year":"2020","unstructured":"Ishikawa Y, Kawashima N, Atsuta Y et al (2020) Prospective evaluation of prognostic impact of KIT mutations on acute myeloid leukemia with RUNX1-RUNX1T1 and CBFB-MYH11. Blood Adv 4(1):66\u201375. https:\/\/doi.org\/10.1182\/bloodadvances.2019000709","journal-title":"Blood Adv"},{"issue":"6","key":"6437_CR34","doi-asserted-by":"publisher","first-page":"792","DOI":"10.3390\/genes12060792","volume":"12","author":"MK Herlin","year":"2021","unstructured":"Herlin MK, Yones SA, Kjeldsen E, Holmfeldt L, Hasle H (2021) What is abnormal in normal karyotype acute myeloid leukemia in children?? Analysis of the mutational landscape and prognosis of the TARGET-AML cohort. Genes (Basel) 12(6):792 Published 2021 May 21. https:\/\/doi.org\/10.3390\/genes12060792","journal-title":"Genes (Basel)"},{"issue":"2","key":"6437_CR35","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1038\/leu.2012.174","volume":"27","author":"A Fasan","year":"2013","unstructured":"Fasan A, Eder C, Haferlach C et al (2013) GATA2 mutations are frequent in intermediate-risk karyotype AML with biallelic CEBPA mutations and are associated with favorable prognosis. Leukemia 27(2):482\u2013485. https:\/\/doi.org\/10.1038\/leu.2012.174","journal-title":"Leukemia"},{"issue":"2","key":"6437_CR36","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1182\/blood-2012-01-403220","volume":"120","author":"PA Greif","year":"2012","unstructured":"Greif PA, Dufour A, Konstandin NP et al (2012) GATA2 zinc finger 1 mutations associated with biallelic CEBPA mutations define a unique genetic entity of acute myeloid leukemia. Blood 120(2):395\u2013403. https:\/\/doi.org\/10.1182\/blood-2012-01-403220","journal-title":"Blood"},{"issue":"50","key":"6437_CR37","doi-asserted-by":"publisher","first-page":"e23569","DOI":"10.1097\/MD.0000000000023569","volume":"99","author":"MG Gao","year":"2020","unstructured":"Gao MG, Hong Y, Qin YZ et al (2020) Prognostic significance of SET-NUP214 fusion gene in acute leukemia after allogeneic hematopoietic stem cell transplantation. Med (Baltim) 99(50):e23569. https:\/\/doi.org\/10.1097\/MD.0000000000023569","journal-title":"Med (Baltim)"},{"issue":"2","key":"6437_CR38","doi-asserted-by":"publisher","first-page":"232","DOI":"10.3324\/haematol.10538","volume":"92","author":"R Rosati","year":"2007","unstructured":"Rosati R, La Starza R, Barba G et al (2007) Cryptic chromosome 9q34 deletion generates TAF-Ialpha\/CAN and TAF-Ibeta\/CAN fusion transcripts in acute myeloid leukemia. Haematologica 92(2):232\u2013235. https:\/\/doi.org\/10.3324\/haematol.10538","journal-title":"Haematologica"},{"issue":"12","key":"6437_CR39","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.1182\/blood-2013-08-521518","volume":"123","author":"R Ben Abdelali","year":"2014","unstructured":"Ben Abdelali R, Roggy A, Leguay T et al (2014) SET-NUP214 is a recurrent \u0393\u03b4 lineage-specific fusion transcript associated with corticosteroid\/chemotherapy resistance in adult T-ALL. Blood 123(12):1860\u20131863. https:\/\/doi.org\/10.1182\/blood-2013-08-521518","journal-title":"Blood"},{"issue":"4","key":"6437_CR40","doi-asserted-by":"publisher","first-page":"2644","DOI":"10.3892\/ol.2016.4260","volume":"11","author":"HH Zhu","year":"2016","unstructured":"Zhu HH, Zhao XS, Qin YZ, Lai YY, Jiang H (2016) B-cell acute lymphoblastic leukemia associated with SET-NUP214 rearrangement: A case report and review of the literature. Oncol Lett 11(4):2644\u20132650. https:\/\/doi.org\/10.3892\/ol.2016.4260","journal-title":"Oncol Lett"},{"issue":"12","key":"6437_CR41","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1056\/NEJMoa1112304","volume":"366","author":"JP Patel","year":"2012","unstructured":"Patel JP, G\u00f6nen M, Figueroa ME et al (2012) Prognostic relevance of integrated genetic profiling in acute myeloid leukemia. N Engl J Med 366(12):1079\u20131089. https:\/\/doi.org\/10.1056\/NEJMoa1112304","journal-title":"N Engl J Med"},{"issue":"6","key":"6437_CR42","doi-asserted-by":"publisher","first-page":"2314","DOI":"10.1182\/blood-2005-11-025536","volume":"109","author":"D Barbaric","year":"2007","unstructured":"Barbaric D, Alonzo TA, Gerbing RB et al (2007) Minimally differentiated acute myeloid leukemia (FAB AML-M0) is associated with an adverse outcome in children: a report from the children\u2019s oncology group, studies CCG-2891 and CCG-2961. Blood 109(6):2314\u20132321. https:\/\/doi.org\/10.1182\/blood-2005-11-025536","journal-title":"Blood"},{"issue":"6","key":"6437_CR43","doi-asserted-by":"publisher","first-page":"e397","DOI":"10.1097\/MPH.0000000000001007","volume":"40","author":"SI Tsujimoto","year":"2018","unstructured":"Tsujimoto SI, Nakano Y, Osumi T et al (2018) A cryptic NUP214-ABL1 fusion in B-cell precursor acute lymphoblastic leukemia. J Pediatr Hematol Oncol 40(6):e397\u2013e399. https:\/\/doi.org\/10.1097\/MPH.0000000000001007","journal-title":"J Pediatr Hematol Oncol"},{"issue":"9","key":"6437_CR44","doi-asserted-by":"publisher","first-page":"e29643","DOI":"10.1002\/pbc.29643","volume":"69","author":"G Veltri","year":"2022","unstructured":"Veltri G, Sandei M, Silvestri D et al (2022) NUP214-ABL1 fusion in childhood T-ALL. Pediatr Blood Cancer 69(9):e29643. https:\/\/doi.org\/10.1002\/pbc.29643","journal-title":"Pediatr Blood Cancer"},{"issue":"4","key":"6437_CR45","doi-asserted-by":"publisher","first-page":"e133","DOI":"10.3324\/haematol.2015.136499","volume":"101","author":"N Duployez","year":"2016","unstructured":"Duployez N, Grzych G, Ducourneau B et al (2016) NUP214-ABL1 fusion defines a rare subtype of B-cell precursor acute lymphoblastic leukemia that could benefit from tyrosine kinase inhibitors. Haematologica 101(4):e133\u2013e134. https:\/\/doi.org\/10.3324\/haematol.2015.136499","journal-title":"Haematologica"},{"key":"6437_CR46","doi-asserted-by":"publisher","first-page":"706798","DOI":"10.3389\/fonc.2021.706798","volume":"11","author":"HP Wang","year":"2021","unstructured":"Wang HP, He JJ, Zhu QY et al (2021) Case report: the first report of NUP214-ABL1 fusion gene in acute myeloid leukemia patient detected by Next-Generation sequencing. Front Oncol 11:706798 Published 2021 Jul 8. https:\/\/doi.org\/10.3389\/fonc.2021.706798","journal-title":"Front Oncol"},{"issue":"5","key":"6437_CR47","doi-asserted-by":"publisher","first-page":"e30203","DOI":"10.1002\/pbc.30203","volume":"70","author":"F de Oliveira Mota","year":"2023","unstructured":"de Oliveira Mota F, Gamba FT, de Carvalho Pires MG et al (2023) NUP214::ABL1: A Ph-like fusion found in a pediatric acute myeloid leukemia patient with normal karyotype. Pediatr Blood Cancer 70(5):e30203. https:\/\/doi.org\/10.1002\/pbc.30203","journal-title":"Pediatr Blood Cancer"},{"key":"6437_CR48","doi-asserted-by":"publisher","first-page":"963689720949175","DOI":"10.1177\/0963689720949175","volume":"29","author":"AL Melo Rodrigues","year":"2020","unstructured":"Melo Rodrigues AL, Bonfim C, Seber A, Colturato VAR, Zecchin VG, Nichele S et al (2020) Allogeneic hematopoietic stem cell transplantation for children and adolescents with acute myeloid leukemia in Brazil: a multicentric retrospective study. Cell Transpl 29:963689720949175","journal-title":"Cell Transpl"},{"issue":"6","key":"6437_CR49","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/S1470-2045(10)70090-5","volume":"11","author":"JE Rubnitz","year":"2010","unstructured":"Rubnitz JE, Inaba H, Dahl G et al (2010) Minimal residual disease-directed therapy for childhood acute myeloid leukaemia: results of the AML02 multicentre trial. Lancet Oncol 11(6):543\u2013552. https:\/\/doi.org\/10.1016\/S1470-2045(10)70090-5","journal-title":"Lancet Oncol"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-025-06437-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-025-06437-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-025-06437-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T05:30:35Z","timestamp":1761283835000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-025-06437-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":49,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["6437"],"URL":"https:\/\/doi.org\/10.1007\/s00277-025-06437-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4550557\/v1","asserted-by":"object"}]},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"8 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This project was approved by the Ethical committee of Federal University of S\u00e3o Paulo in accordance with the regulations of this committee, approval number 0715P\/2021, CAAE: 48326921.4.0000.5505.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}